Biovec, LLC
Records under this name other than patents Biovec, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,420,075 | Ex Vivo and in Vivo Expression of the Thrombomodulin Gene for the Treatment of Cardiovascular and Peripheral Vascular Diseases Lapsed on the fee record Ended Apr 16, 2021 · High confidence | Lapsed on the fee record | Ended Apr 16, 2021 | High confidence |
| US 7,501,114 | Ex Vivo and in Vivo Expression of the Thrombomodulin Gene for the Treatment of Cardiovascular and Peripheral Vascular Diseases Lapsed on the fee record Ended Mar 10, 2021 · High confidence | Lapsed on the fee record | Ended Mar 10, 2021 | High confidence |
| US 8,367,056 | In Vivo and Ex Vivo Gene Transfer into Renal Tissue Using Gutless Adenovirus Vectors Lapsed on the fee record Ended Feb 5, 2021 · Medium confidence | Lapsed on the fee record | Ended Feb 5, 2021 | Medium confidence |
| US 7,481,998 | Ex Vivo and in Vivo Expression of the Thrombomodulin Gene for the Treatment of Cardiovascular and Peripheral Vascular Diseases Lapsed on the fee record Ended Jan 27, 2021 · High confidence | Lapsed on the fee record | Ended Jan 27, 2021 | High confidence |
| US 8,242,095 | In Vivo and Ex Vivo Gene Transfer into Renal Tissue Using Gutless Adenovirus Vectors Lapsed on the fee record Ended Aug 14, 2020 · Medium confidence | Lapsed on the fee record | Ended Aug 14, 2020 | Medium confidence |
| US 8,236,300 | In Vivo and Ex Vivo Gene Transfer into Renal Tissue Using Gutless Adenovirus Vectors Lapsed on the fee record Ended Aug 7, 2020 · Low confidence | Lapsed on the fee record | Ended Aug 7, 2020 | Low confidence |
| US 9,388,427 | In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors Lapsed on the fee record Ended Jul 12, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jul 12, 2020 | From the USPTO record |
| US 9,353,383 | In Vivo and Ex Vivo Gene Transfer into Renal Tissue Using Gutless Adenovirus Vectors Lapsed on the fee record Ended May 31, 2020 · Medium confidence | Lapsed on the fee record | Ended May 31, 2020 | Medium confidence |
| US 8,142,992 | A Platelet Preservation Package Comprising a Short to Ultra-Short Acting Antiplatelet Agent and Anticoagulant with an Oxygen Carrier Formerly held Lapsed on the fee record Ended Mar 27, 2020 · Medium confidence | Lapsed on the fee record | Ended Mar 27, 2020 | Medium confidence |
| US 8,129,103 | Use of a Platelet Preservation Composition Comprising a Short to Ultra-Short Acting Antiplatelet Agent and Anticoagulant with an Oxygen Carrier Formerly held Lapsed on the fee record Ended Mar 6, 2020 · Medium confidence | Lapsed on the fee record | Ended Mar 6, 2020 | Medium confidence |